Prudential Financial’s Fusion Pharmaceuticals FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-14,600
Closed -$44K – 2728
2022
Q3
$44K Buy
+14,600
New +$36.5K ﹤0.01% 2567

Other funds holding FUSN

Prudential Financial's FUSN Position: Q4 2022 in Review

Prudential Financial sold out of Fusion Pharmaceuticals (FUSN) in Q4 2022, closing a stake of 14,600 shares — an estimated $44K sold.

Prudential Financial first reported a position in FUSN in Q3 2022 and held it in 1 quarter. The position peaked at $44K in Q3 2022. 31 funds tracked by Wall St. Rank hold FUSN as of Q4 2022.

  • Prudential Financial reported no remaining Fusion Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Prudential Financial sold 14,600 Fusion Pharmaceuticals shares in Q4 2022, an estimated $44K.
  • Prudential Financial first reported a position in Fusion Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • Prudential Financial's Fusion Pharmaceuticals position peaked at $44K in Q3 2022.
  • 31 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.